A light-blue semaglutide injection pen lying on a grey surface
File photo: HualinXMN / Wikimedia Commons, CC BY-SA 4.0 · an Ozempic pen sold in China, June 2023. Ozempic contains semaglutide, the same medicine as Wegovy
Health419 under-18 prescriptions in 2025-26 · 341 more in April–July 2026 · private ones not counted

Weight-loss jabs: hundreds of prescriptions went to under-18s in England

Why it hits youIn England, 22.8% of Year 6 children (ages 10 and 11) are living with obesity, according to the National Child Measurement Programme. These medicines are changing how the NHS treats the most serious cases. The figures leave out private prescriptions and drugs handed out in hospitals, so the real number is likely to be higher. It also isn't clear how many were mainly for weight loss, since some GLP-1s are diabetes medicines too.

New figures obtained by the Guardian show 419 prescriptions for GLP-1 medicines, the group of drugs that includes Wegovy and Mounjaro, went to under-18s in England in 2025-26. Ten were for children under 12. In just four months this year, April to July, there were 341 more, 15 of them for under-12s. Doctors who run specialist NHS clinics say the jabs can transform the lives of children living with severe obesity and serious health problems. Others warn there's little long-term evidence in growing children, and say stopping obesity before it starts matters more.

The Facts

What everyone agrees on

Before anyone spins it. Every one of these is checkable.

  • In the 2025-26 financial year there were 419 prescriptions for GLP-1 medicines issued to under-18s in England, 10 of them for children under 12. The figures came from the NHS Business Services Authority through freedom of information requests. The Guardian ↗

  • From April to July 2026, 341 GLP-1 prescriptions were issued to children, 15 of them for under-12s. The Guardian ↗

  • The figures don't include private prescriptions, or medicines given out in hospitals or prisons, so they are likely to be a considerable underestimate. It's also unclear whether they were mainly for weight loss. The Guardian ↗

  • NHS England says 6,497 children and young people have been treated at its specialist CEW clinics since they started in 2021, including 3,137 teenagers aged 13 to 17. LBC ↗

  • Wegovy is licensed for weight management in young people aged 12 and over who have obesity and weigh more than 60kg. It is not recommended for under-12s. Wegovy patient leaflet (emc) ↗

  • Mounjaro can be used by children aged 10 and over for type 2 diabetes, but its leaflet says it should not be given to under-18s for weight management. Mounjaro patient leaflet (emc) ↗

  • NICE, which decides which medicines the NHS should fund, has made no recommendation on Wegovy for 12 to 17-year-olds because the maker, Novo Nordisk, didn't submit evidence. NICE ↗

  • The World Health Organization's first guidelines on child obesity, published in October 2026, don't recommend obesity medicines for children aged nine and under. For 10 to 19-year-olds, they say medicines may be considered only when a supervised lifestyle programme hasn't worked. Pharmaceutical Technology ↗

Every Side · 1 of 3

Specialist NHS doctors and families

“…the first time they feel they have any agency in their lives at all”

Professor Julian Hamilton-Shield works at a specialist children's clinic in Bristol. He says children who get semaglutide there have usually not been helped by diet advice and psychological support, and most have other illnesses such as type 2 diabetes or sleep apnoea. “It is used quite frequently and it is a very effective drug,” he said. “Nobody's saying that every child who's a bit heavy should have a GLP-1.” He said the children often have “enormous lack of self-esteem” and “all the stigma”, and losing weight can be “the first time they feel they have any agency in their lives at all”. Dr Dunia Ismail, a consultant paediatrician who runs a similar clinic, said: “We know now that obesity is not a choice, it's a condition.” Lilly, 15, was prescribed the jabs at 13. She told ITV News: “It's just been completely life-changing.” Her mum Sarah said: “This is for children who have fought like hell to change.”

Who's saying it
  • Prof Julian Hamilton-Shield, Bristol CEW clinic
  • Dr Dunia Ismail, consultant paediatrician
  • Lilly, 15, and her mum Sarah (ITV News)

Side labels are our editorial calls for now. How we'll rate lean

Every Side · 2 of 3

What it means for you

Only through specialist care, and not every jab is allowed for under-18s

On the NHS, under-18s get these medicines through specialist children's clinics called Complications from Excess Weight (CEW) clinics. They're for young people with severe obesity and serious health problems caused by their weight, when other help hasn't worked. NHS England's Professor Simon Kenny said the drugs “are only prescribed following careful assessment by paediatric specialists”. Wegovy's official leaflet says it can be used “for weight management in adolescents ages 12 years and above”, and isn't recommended for under-12s. Mounjaro's leaflet says it should not be given to under-18s “for weight management because it has not been studied in these age groups”. The NHS lists common side effects of semaglutide as feeling or being sick, constipation, diarrhoea, tiredness and hair loss. If anyone gets it privately, the NHS says “it's important to buy it from a registered pharmacy. There are some websites that sell fake weight loss medicines.” If you're worried about your eating or someone else's, the NHS says to see a GP, or call the eating disorder charity Beat's helpline on 0808 801 0677.

Who's saying it
  • NHS
  • NHS England
  • Wegovy and Mounjaro patient leaflets

Side labels are our editorial calls for now. How we'll rate lean

Every Side · 3 of 3

Cautious doctors, dietitians and campaigners

“For the majority of children, weight loss injections shouldn't become the go-to”

That's Bahee Van de Bor of the British Dietetic Association. “We really need to think about addressing the root causes,” she told ITV News. Professor Martin Whyte of the University of Surrey said children on the jabs need regular checks on growth, puberty, mental health and eating behaviours, partly “because we know weight tends to return when the drugs are stopped, and partly because we still have limited data on use over many years in growing young people.” Last month the World Health Organization said under-10s should not get obesity medicines. Its nutrition director, Dr Luz María De Regil, said: “The foundation of obesity care for children and adolescents is not medicine or surgery.” Katharine Jenner of the Obesity Health Alliance said: “Children today are growing up surrounded by unhealthy food at almost every turn.” Writing in the Pharmaceutical Journal about GLP-1s in general, two authors raised “significant concerns” that they may be misused by people with eating disorders.

Who's saying it
  • Bahee Van de Bor, British Dietetic Association
  • Prof Martin Whyte, University of Surrey
  • World Health Organization
  • Obesity Health Alliance

Side labels are our editorial calls for now. How we'll rate lean

The Blindspot · what the headlines skip

Supporters skip what happens when the jabs stop

Professor Whyte says weight “tends to return when the drugs are stopped”. A private doctor who treats young people with the jabs wrote in the Telegraph that none of her adolescent patients “have yet come off the drugs”. Nobody yet knows what years of use means for a body that is still growing.

The Guardian ↗The Telegraph (via Yahoo) ↗

The Blindspot · what the headlines skip

The official figures miss private prescribing

One private clinic for children has said it has more than 200 patients on the jabs, and private prescriptions aren't in the NHS figures. Private GP Dr Sindy Newman wrote that her clinic offers Wegovy or Mounjaro to young people, at £100 for a first consultation and £165 for four weeks of medicine. She said: “I'm only seeing the children of parents who have resources to afford help.”

The Guardian ↗The Telegraph (via Yahoo) ↗

The Blindspot · what the headlines skip

Prevention doesn't help children who are already ill

Critics focus on stopping obesity early. But the children getting jabs on the NHS are mostly ones where other help has already failed, and many already have type 2 diabetes, sleep apnoea or liver disease. A Leeds specialist says many of her patients come from poorer areas: “Poverty plays a massive part – some of our families can't afford healthier food.”

The Guardian ↗ITV News (via STV) ↗

Your Call

Should specialist NHS clinics be able to give weight-loss jabs to children with severe obesity and serious health problems?

Which side surprised you most?

Sides you've read
  1. Specialist NHS doctors and families: not yet
  2. What it means for you: not yet
  3. Cautious doctors, dietitians and campaigners: not yet

Only you can see this. It's saved on this device and never sent anywhere.

Receipts

Every source, one tap away

Don't take our word for it. This is everything the breakdown is built on.

Hero image: File photo: HualinXMN / Wikimedia Commons, CC BY-SA 4.0 · an Ozempic pen sold in China, June 2023. Ozempic contains semaglutide, the same medicine as Wegovy ↗

By No Glaze News · published

Next story Some crimes from when you were under 18 could stop following you for life
Next story